Back
Neumora Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
NMRA
Neumora Therapeutics
Last Price:
$0.77
Seasonality Move:
11.53%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing slight selling pressure.
Neumora Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Buy |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 1.17 | Sell |
| 200-day SMA: | 7.89 | Sell |
| 8-day EMA: | 0.72 | Buy |
| 20-day EMA: | 0.81 | Sell |
| 50-day EMA: | 1.53 | Sell |
| 200-day EMA: | 6.31 | Sell |
Neumora Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 35.59 | Sell |
| Chaikin Money Flow: | 549811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Neumora Therapeutics Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neumora Therapeutics Stock
Is Neumora Therapeutics Stock a Buy?
-
Neumora Therapeutics share price is 0.76 while NMRA 8-day simple moving average is 0.69, which is a Buy signal.
-
The stock price of NMRA is 0.76 while Neumora Therapeutics 20-day SMA is 0.76, which makes it a Sell.
-
Neumora Therapeutics 50-day simple moving average is 1.17 while NMRA share price is 0.76, making it a Sell technically.
-
NMRA stock price is 0.76 and Neumora Therapeutics 200-day simple moving average is 7.89, creating a Sell signal.
NMRA Technical Analysis vs Fundamental Analysis
Sell
23
Neumora Therapeutics (NMRA)
is a Sell
Is Neumora Therapeutics a Buy or a Sell?
-
Neumora Therapeutics stock is rated a SellThe current Neumora Therapeutics [NMRA] share price is $0.76. The Score for NMRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Neumora Therapeutics Stock Info
Market Cap:
122.7M
Price in USD:
0.76
Share Volume:
911.3K
Neumora Therapeutics 52-Week Range
52-Week High:
17.19
52-Week Low:
0.62
Sell
23
Neumora Therapeutics (NMRA)
is a Sell
Neumora Therapeutics Share Price Forecast
-
What is the Neumora Therapeutics stock price today?The Neumora Therapeutics stock price is 0.76 USD today.
-
Will NMRA stock go up or go down?Neumora Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Neumora Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neumora Therapeutics is overvalued.
Is Neumora Therapeutics Stock a Buy?
-
Neumora Therapeutics share price is 0.76 while NMRA 8-day exponential moving average is 0.72, which is a Buy signal.
-
The stock price of NMRA is 0.76 while Neumora Therapeutics 20-day EMA is 0.81, which makes it a Sell.
-
Neumora Therapeutics 50-day exponential moving average is 1.53 while NMRA share price is 0.76, making it a Sell technically.
-
NMRA stock price is 0.76 and Neumora Therapeutics 200-day simple moving average is 6.31, creating a Sell signal.
Fundamental Analysis of Neumora Therapeutics
Is Neumora Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.08 per share, and an increase next year of $0.14 per share.
Technical Analysis of Neumora Therapeutics
Should I short Neumora Therapeutics stock?
-
NMRA Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Neumora Therapeutics is a Sell
-
Neumora Therapeutics Relative Strength Index (RSI) is 35.59, which suggest Neumora Therapeutics is oversold
-
The Bollinger Bands (25) for Neumora Therapeutics is ( - ), which suggest Neumora Therapeutics is a Buy
-
The Bollinger Bands (100) for Neumora Therapeutics is ( - ), which suggest Neumora Therapeutics is a Buy
* Neumora Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.